{
Marjorie Green

People

}
001122334455554433221100
001122334455554433221100

merck"s injectable keytruda shows comparable efficacy to intravenous formulation in trial

Merck announced that its injectable version of Keytruda is not inferior to the approved intravenous formulation in a late-stage trial for lung cancer patients. The injectable method, which takes about 2-3 minutes to administer, could enhance accessibility and protect the drug from future competition as the IV version nears patent expiration. Merck plans to engage with global regulators regarding these promising results.
CNBC
United States Dollar Merck & Co., Inc. USA Marjorie Green
Healthcare, News Article
13:22 19.11.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Finance Mergers & Acquisitions Global Financial Events Financial Scams and Security Retail and Consumer Goods Market Analysis and Predictions Hedge Funds & Private Equity Banking Regulations CEO Changes AI Innovations Supply Chain Management Global Trade Developments Industry Mergers & Acquisitions Workplace Trends Funding Rounds & Investments Startups & Entrepreneurship Cryptocurrency Trends Government Economic Policies
Countries:
USA CHN IND GBR CAN TWN ARE CHE DEU JPN SAU FRA HKG SGP KOR ITA BRA VNM NLD COL
Companies:
JPMorgan Chase & Co. Barclays PLC NVIDIA Corporation Morgan Stanley Tesla, Inc. The Goldman Sachs Group, Inc. Bank of America Corporation Citigroup Inc. Wells Fargo & Company The Charles Schwab Corporation Capital One Financial Corporation Apple Inc. Huawei Technologies CO. Ltd. Netflix, Inc. Tesmec S.p.A. Truist Financial Corp HSBC Holdings plc Geode Capital Management LLC State Street Corporation Microsoft Corporation
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro British Pound Sterling Swiss Franc United Arab Emirates Dirham Japanese Yen South Korean Won Canadian Dollar Offshore Chinese Yuan Singapore Dollar Azerbaijani Manat New Taiwan Dollar Saudi Riyal Vietnamese Đồng Hong Kong Dollar Brazilian Real Colombian Peso
People:
Donald Trump Elon Musk Dan Ives Jerome Powell Troy L Rohrbaugh Robin Leopold Raja Akram Rick Wurster Joe Biden Warren Buffett Jamie Dimon Bruce Westerman Paul Triolo Walter W Bettinger II Jensen Huang Jennifer Piepszak Anand Selvakesari Mark Mason Howard Silverblatt Raimo Lenschow

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.